Clinical trial
FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide)…
NCT00270361 · Scios, Inc., Industry · Completed
Key facts
| NCT number | NCT00270361 |
|---|---|
| Title | FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hospitalization. |
| Official title | Management of Patients With CHF After Hospitalization-Follow up Serial Infusions of NATRECOR (Nesiritide) - FUSION I, A Pilot Study |
| Lead sponsor | Scios, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | nesiritide, usual long term cardiac medications |
| Enrollment | 214 |
| Start date | Dec 1, 2001 |
| Completion | Jan 1, 2003 |
| First posted | Dec 26, 2005 |
| Last update posted | Jul 26, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: